Lisa Zack, MD
Dermatopathology · Naples, FLNPI 1467458984
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Organogenesis Inc. at 30.1% of the total.
Across 46 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$275
- Novartis$79
- Almirall LLC$74
- Johnson & Johnson$72
- LEO Pharma Inc.$72
- Biofrontera Inc.$69
- plus $274 from 10 others
What the payments were for
- Food & beverage$914100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 11 | $275 |
| Novartis | 4 | $79 |
| Almirall LLC | 3 | $74 |
| Johnson & Johnson | 4 | $72 |
| LEO Pharma Inc. | 4 | $72 |
| Biofrontera Inc. | 4 | $69 |
| AbbVie(2 entities) | 2 | $41 |
| Strata Skin Sciences, Inc. | 3 | $40 |
| Galderma Laboratories, L.p. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Genentech USA, Inc. | 2 | $30 |
| Merck | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Dermavant Sciences, Inc. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Pfizer | 1 | $17 |
How this compares
$914 in reported general payments places this provider in the 75th percentile of 62 dermatopathology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 164 | $1,215 |
| Mupirocin | 110 | $798 |
| Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate | 12 | $84 |
| Ciprofloxacin Hcl | 14 | $71 |
| Levofloxacin | 15 | $49 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Naples
- Rishi PatelBrooksville$38K
- John MillnsTampa$8K
- Daniel RivlinMiami Beach$3K
- Allison ArthurOrlando$3K
- Mustafa MohammadTampa$3K
- Andras SchafferTallahassee$3K
- Mazen DaoudFort Myers$2K
- Michael HennerMount Dora$2K
- Wonwoo ShonGainesville$1K
- Sairekha RavichandranTampa$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.